Common medications in this class include semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and tirzepatide (Mounjaro, Zepbound), though tirzepatide is technically a dual GLP-1/GIP receptor agonist
A common method for tracking symptoms is using a notes app or writing them down on paper whenever they come to mind
Evaluation of the novel DiaSorin LIAISON
WB4-24, a non-peptide GLP-1 receptor agonist, demonstrated dose-dependent attenuation in mouse models of acute and chronic inflammatory nociception via the release of -endorphins from spinal microglia [17]
Studies suggest a correlation between using GLP-1 drugs and an increased risk of developing thyroid cancers
Yes, you may be able to file a lawsuit if you used Ozempic off-label for weight loss and experienced adverse effects